Breast cancer outcomes based on method of detection in community-based breast cancer registry
- PMID: 37878149
- DOI: 10.1007/s10549-023-07092-x
Breast cancer outcomes based on method of detection in community-based breast cancer registry
Abstract
Purpose: The impact of opportunistic screening mammography in the United States is difficult to quantify, partially due to lack of inclusion regarding method of detection (MOD) in national registries. This study sought to determine the feasibility of MOD collection in a multicenter community registry and to compare outcomes and characteristics of breast cancer based on MOD.
Methods: We conducted a retrospective study of breast cancer patients from a multicenter tumor registry in Missouri from January 2004 - December 2018. Registry data were extracted by certified tumor registrars and included MOD, clinicopathologic information, and treatment. MOD was assigned as screen-detected or clinically detected. Data were analyzed at the patient level. Chi-squared tests were used for categorical variable comparison and Mann-Whitney-U test was used for numerical variable comparison.
Results: 5351 women (median age, 63 years; interquartile range, 53-73 years) were included. Screen-detected cancers were smaller than clinically detected cancers (median size 12 mm vs. 25 mm; P < .001) and more likely node-negative (81% vs. 54%; P < .001), lower grade (P < .001), and lower stage (P < .001). Screen-detected cancers were more likely treated with lumpectomy vs. mastectomy (73% vs. 41%; P < .001) and less likely to require chemotherapy (24% vs. 52%; P < .001). Overall survival for patients with invasive breast cancer was higher for screen-detected cancers (89% vs. 74%, P < .0001).
Conclusion: MOD can be routinely collected and linked to breast cancer outcomes through tumor registries, with demonstration of significant differences in outcome and characteristics of breast cancers based on MOD. Routine inclusion of MOD in US tumor registries would help quantify the impact of opportunistic screening mammography in the US.
Keywords: Breast cancer; Mammography; Method of detection; Registry; Screening.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Community-Based Breast Cancer Screening Using Digital Breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.AJR Am J Roentgenol. 2022 Feb;218(2):249-257. doi: 10.2214/AJR.21.26384. Epub 2021 Sep 15. AJR Am J Roentgenol. 2022. PMID: 34523954
-
Mode of detection matters: Differences in screen-detected versus symptomatic breast cancers.Clin Imaging. 2021 Dec;80:11-15. doi: 10.1016/j.clinimag.2021.06.032. Epub 2021 Jun 26. Clin Imaging. 2021. PMID: 34218078
-
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Health Technol Assess. 2011. PMID: 21951942 Free PMC article. Review.
-
Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.AJR Am J Roentgenol. 2005 Jan;184(1):324-9. doi: 10.2214/ajr.184.1.01840324. AJR Am J Roentgenol. 2005. PMID: 15615996
-
Tubular breast cancer experience at Washington University: a review of the literature.Clin Breast Cancer. 2001 Oct;2(3):210-4. doi: 10.3816/CBC.2001.n.023. Clin Breast Cancer. 2001. PMID: 11899414 Review.
References
-
- Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G et al (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast Cancer screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1(8433):829–832 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical